Related Experiment Video
Updated: Aug 17, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients
Sevcan A Bakkaloglu1, Necla Buyan, Tohru Funahashi
1Department of Pediatric Nephrology, Gazi University, Ankara, Turkey. sevcan@gazi.edu.tr
Insights
In pediatric patients on chronic peritoneal dialysis (CPD), serum adiponectin (ADPN) levels were inversely associated with creatinine. This suggests ADPN may be a novel prognostic marker for cardiovascular risk in these children.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Risk Assessment
- Renal Disease Biomarkers
Background:
- Atherosclerotic vascular diseases are a leading cause of mortality in pediatric end-stage renal disease (ESRD) patients undergoing chronic peritoneal dialysis (CPD).
- Adiponectin (ADPN), an anti-atherogenic protein, is elevated in ESRD, but low levels are linked to cardiovascular death.
- The role of ADPN in pediatric CPD patients requires further clarification.
Purpose of the Study:
- To investigate atherosclerotic risk factors in children on CPD.
- To determine the significance of serum adiponectin (ADPN) levels in pediatric CPD patients.
Main Methods:
- A cross-sectional study was conducted in a university hospital's pediatric peritoneal dialysis unit.
- 18 children on CPD and 20 healthy controls were assessed for serum ADPN, blood pressure, glucose, lipids, apolipoprotein B, C-reactive protein (CRP), lipoprotein(a), and homocysteine.
- Statistical analysis correlated ADPN levels with clinical parameters.
Main Results:
- Serum ADPN levels were significantly higher (threefold) in pediatric CPD patients compared to controls.
- Apolipoprotein B and CRP levels were also elevated in the CPD group.
- A significant negative correlation was observed between log ADPN and creatinine levels (r = -0.54, p < 0.05) in CPD patients.
Conclusions:
- Serum ADPN levels are inversely associated with creatinine in pediatric CPD patients.
- ADPN may serve as a novel predictive marker for prognosis in pediatric patients with ESRD on CPD.
- Further research is warranted to validate ADPN as a biomarker for cardiovascular risk in this population.
Background:
Atherosclerotic vascular diseases are the major cause of mortality in patients with end-stage renal disease (ESRD) treated with chronic peritoneal dialysis (CPD), even in children. Adiponectin (ADPN) is a recently discovered adipocyte-derived plasma protein having anti-atherogenic properties. ADPN levels are elevated in ESRD but it has been reported that ESRD patients with low plasma ADPN levels have a high risk of cardiovascular death.
Objective:
To clarify the atherosclerotic risk and especially the significance of ADPN levels in pediatric patients on CPD.
Design:
Cross-sectional studyin the pediatric peritoneal dialysis unit of a university hospital.
Patients:
18 children, aged 12.6 +/- 5.6 years, being treated with CPD and 20 healthy age- and sex-matched control subjects were enrolled in this study.
Methods:
Serum ADPN levels and other risk factors, including blood pressure, blood glucose, serum lipid/lipoprotein fractions, apolipoprotein B, C-reactive protein (CRP), lipoprotein(a), and homocysteine levels, were studied in CPD patients and compared to the controls.
Results:
Serum ADPN levels were three times higher in the CPD group compared to the control subjects, as was previously reported. Apolipoprotein B and CRP levels were also high in the CPD group. No significant difference was found in other atherosclerotic parameters, including lipoprotein(a) and homocysteine levels. Interestingly, we found a negative correlation between log ADPN and creatinine levels among the CPD patients (r = -0.54, p < 0.05). There was no correlation between log ADPN and duration of CPD. Creatinine and low-density lipoprotein levels could account for 54% of the total variation in ADPN levels.
Conclusion:
Among pediatric CPD patients, serum levels of the anti-atherogenic protein, ADPN, were inversely associated with creatinine. ADPN level might be a novel marker to predict prognosis in pediatric CPD patients.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis III: Nursing Management
Peripheral Artery Disease I: Introduction
Chronic Kidney Disease I: Introduction